Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
about
NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathwayDNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A bindingYeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.
P2860
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
@en
type
label
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
@en
prefLabel
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
@en
P2860
P356
P1476
Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
@en
P2093
Catherine H Wilson
Jason S Kerr
P2860
P304
P356
10.1042/BST20130069
P577
2013-08-01T00:00:00Z